Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2659 |
|
Actual shortage: | 251 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2399 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
27 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ACT CIPROFLOXACIN | 750MG | TABLET | Resolved | 2022-10-28 | 2023-06-09 | 173040 |
TEVA-CEPHALEXIN 125 | 125MG | POWDER FOR SUSPENSION | Resolved | 2022-10-28 | 2024-02-14 | 173037 |
TEVA-AMPICILLIN | 500MG | CAPSULE | Resolved | 2022-10-28 | 2022-11-12 | 173034 |
TEVA-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Resolved | 2022-10-28 | 2022-12-15 | 173031 |
TEVA-SUMATRIPTAN DF | 25MG | TABLET | Resolved | 2022-10-28 | 2022-11-12 | 173028 |
TEVA-FENTANYL | 100MCG | PATCH | Resolved | 2022-10-28 | 2022-12-02 | 173025 |
TEVA-FENTANYL | 12MCG | PATCH | Resolved | 2022-10-28 | 2022-12-02 | 173022 |
TEVA-FENTANYL | 25MCG | PATCH | Resolved | 2022-10-28 | 2022-12-02 | 173019 |
TEVA-FENTANYL | 50MCG | PATCH | Resolved | 2022-10-28 | 2022-12-02 | 173016 |
TEVA-FENTANYL | 75MCG | PATCH | Resolved | 2022-10-28 | 2022-12-02 | 173013 |
TEVA-AZATHIOPRINE | 50MG | TABLET | Resolved | 2022-10-28 | 2022-12-08 | 173010 |
TEVA-CEPHALEXIN | 250MG | CAPSULE | Resolved | 2022-10-28 | 2023-10-03 | 173007 |
TEVA-TERIPARATIDE INJECTION | 250MCG | SOLUTION | Resolved | 2022-10-28 | 2022-12-15 | 173004 |
TEVA-SERTRALINE | 50MG | CAPSULE | Resolved | 2022-10-28 | 2023-01-18 | 173000 |
NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2022-10-20 | 2024-02-14 | 172263 |
TEVA-PREDNISOLONE | 1% | SUSPENSION | Resolved | 2022-10-17 | 2023-06-09 | 172030 |
TEVA-AMPHETAMINE XR | 10MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2022-10-17 | 2023-07-28 | 172027 |
TEVA-PIROXICAM | 20MG | CAPSULE | Resolved | 2022-10-17 | 2023-10-19 | 172024 |
TEVA-PANTOPRAZOLE MAGNESIUM | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-10-17 | 2022-12-08 | 172021 |
TEVA-FUROSEMIDE | 20MG | TABLET | Resolved | 2022-10-17 | 2023-07-12 | 172018 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14039 |
LEUCOVORIN CALCIUM INJECTION | 10MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14036 |
GEMCITABINE FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14033 |
ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |
EPTIFIBATIDE INJECTION | 2MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14027 |
EPTIFIBATIDE INJECTION | 0.75MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14024 |
CLOXACILLIN SODIUM FOR INJECTION | 2G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14021 |
CLOXACILLIN SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14018 |
CLOXACILLIN SODIUM FOR INJECTION | 500MG | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14014 |
TEVA-PRAMIPEXOLE | 1.5MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14007 |